Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. It is approved for the treatment of...
18 KB (1,443 words) - 15:56, 15 June 2025
Deulumateperone (redirect from Lumateperone deuterated)
ITI-1284) is an experimental antipsychotic and deuterated analogue of lumateperone which is under development as a sublingually administered orally disintegrating...
4 KB (172 words) - 03:40, 3 March 2025
Levosulpiride – approved in low doses for major depressive disorder Lumateperone (Caplyta) – approved as a monotherapy for bipolar depression Lurasidone...
18 KB (1,537 words) - 20:49, 7 May 2025
simplification of the 5-HT2A antagonist atypical antipsychotic drug lumateperone along with several related compounds such as IHCH-7086, which was found...
3 KB (252 words) - 06:00, 9 April 2025
Haloperidol, the most widely used classical antipsychotic drug in this class Lumateperone, an atypical antipsychotic used for schizophrenia and bipolar depression...
3 KB (209 words) - 13:39, 30 March 2025
the FDA in the United States. Cariprazine, Quetiapine, lurasidone, and lumateperone have been approved, as monotherapies, for bipolar depression, but as...
102 KB (9,281 words) - 20:03, 29 May 2025
of first-generation (typical) antipsychotics. Lumateperone (Caplyta) – In December 2019, lumateperone, a presynaptic D2 receptor partial agonist and...
224 KB (19,556 words) - 11:08, 28 June 2025
simplification of the 5-HT2A receptor antagonist atypical antipsychotic drug lumateperone along with several related compounds such as IHCH-7079 and IHCH-7086...
3 KB (204 words) - 03:41, 11 April 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
93 KB (8,725 words) - 15:16, 23 June 2025
Levomepromazine, Lisdexamfetamine, Lithium, Lorazepam, Lorediplon, Loxapine, Lumateperone, Lurasidone Maprotiline, Melperone, Meprobamate, Mesoridazine, Methamphetamine...
3 KB (218 words) - 14:07, 2 July 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
5 KB (291 words) - 08:04, 22 May 2025
simplification of the 5-HT2A antagonist atypical antipsychotic drug lumateperone along with several related compounds such as IHCH-7079, which was found...
3 KB (249 words) - 15:09, 20 February 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
57 KB (5,444 words) - 21:59, 2 July 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
3 KB (201 words) - 23:51, 22 June 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
39 KB (3,411 words) - 21:07, 29 May 2025
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
147 KB (13,440 words) - 19:13, 30 June 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
140 KB (14,357 words) - 03:16, 14 June 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
179 KB (16,517 words) - 01:53, 3 July 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
3 KB (148 words) - 03:52, 30 June 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
33 KB (2,736 words) - 21:59, 29 May 2025
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
170 KB (16,585 words) - 22:58, 23 June 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
6 KB (454 words) - 06:58, 5 June 2025
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
20 KB (1,746 words) - 22:40, 30 June 2025
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
50 KB (4,593 words) - 15:05, 24 June 2025
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
13 KB (964 words) - 21:08, 17 October 2024
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
63 KB (23,109 words) - 01:23, 1 July 2025
lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063 Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724 Adrafinil Aplindore...
25 KB (1,583 words) - 01:53, 1 July 2025
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
57 KB (5,519 words) - 00:11, 24 June 2025
clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone". European Neuropsychopharmacology. 29 (9): 971–985. doi:10.1016/j.euroneuro...
62 KB (5,232 words) - 00:58, 23 June 2025
Diphenylprolinol DMBMPP Ergolines (e.g., LSD) GYKI-52895 HDMP-29 Ivabradine Lumateperone and analogues (e.g., IHCH-7079, IHCH-7086, IHCH-7113, ITI-1549) Methoxphenidine...
29 KB (2,556 words) - 17:51, 22 June 2025